For instance, Xu et al. established that in HNSCC, there is an obstruction to Nrf2 degradation mediated by the ubiquitin-proteasome pathway, leading to Nrf2 accumulation, which may contribute to the development of acquired cisplatin resistance in HNSCC 113. The gene discussed is NFE2L2; the disease is head and neck squamous cell carcinoma.